Prognostic significance of paraglottic space invasion in T2N0 glottic carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 2, 2007, Pages 186-190

  Dagan, Roi ^a   Morris, Christopher G ^a   Bennett, Jeffrey A ^a   Mancuso, Anthony A ^a   Amdur, Robert J ^a   Hinerman, Russell W ^a   Mendenhall, William M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Glottic carcinoma; Paraglottic space invasion; Radiotherapy

Indexed keywords

ARTICLE; CANCER CONTROL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR VOLUME;

ANALYSIS OF VARIANCE; DOSE FRACTIONATION; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34147175046     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000251403.54180.df     Document Type: Article

References (29)

1. What Are the Key Statistics About Laryngeal and Hypopharyngeal Cancers? American Cancer Society; 2006.
2. Rafferty MA, Fenton JE, Jones AS. The history, aetiology and epidemiology of laryngeal carcinoma. Clin Otolaryngol Allied Sci. 2001;26: 442-446.
3. Tuyns AJ. Laryngeal cancer. Cancer Surv. 1994;19-20:159-173.
4. Mendenhall WM, Werning JW, Hinerman RW, et al. Management of T1-T2 glottic carcinomas. Cancer. 2004;100:1786-1792.
5. Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19:4029-4036.
6. Murakami R, Nishimura R, Baba Y, et al. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system. Int J Radiat Oncol Biol Phys. 2005;61:471-475.
7. Prehn RB, Pasic TR, Harari PM, et al. Influence of computed tomography on pretherapeutic tumor staging in head and neck cancer patients. Otolaryngol Head Neck Surg. 1998;119:628-633.
8. Bloom C, Just N, Remy H, et al. Laryngeal cancer: is computed tomography a valuable imaging technique? A retrospective analysis. Can Assoc Radiol J. 1998;49:370-377.
9. Mukherji SK, Mancuso AA, Mendenhall W, et al. Can pretreatment CT predict local control of T2 glottic carcinomas treated with radiation therapy alone? AJNR Am J Neuroradiol. 1995;16:655-662.
10. Hermans R, Van den BW, Rijnders A, et al. Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters. Radiother Oncol. 1999;50:39-46.
11. Marshak G, Brenner B, Shvero J, et al. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys. 1999;43:1009-1013.
12. Nur DA, Oguz C, Kemal ET, et al. Prognostic factors in early glottic carcinoma implications for treatment. Tumori. 2005;91:182-187.
13. Raitiola H, Wigren T, Pukander J. Radiotherapy outcome and prognostic factors in early glottic carcinoma. Auris Nasus Larynx. 2000;27:153-159.
14. Burke LS, Greven KM, McGuirt WT, et al. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys. 1997;38:37-42.
15. Sakata K, Aoki Y, Karasawa K, et al. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int J Radiat Oncol Biol Phys. 1994;30:1059-1064.
16. Yamamoto M, Hada Y, Shirane M, et al. The results of radiation therapy for glottic carcinoma: prognostic significance of tumor size in laryngoscopic findings. Oncol Rep. 2000;7:1275-1277.
17. Murakami R, Furusawa M, Baba Y, et al. Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy. AJNR Am J Neuroradiol. 2000;21:1320-1326.
18. Lo SM, Venkatesan V, Matthews TW, et al. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma. J Otolaryngol. 1998;27:247-257.
19. Pameijer FA, Mancuso AA, Mendenhall WM, et al. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys. 1997;37:1011-1021.
20. International Union Against Cancer. TNM Classification of Malignant Tumours, 6th ed. New York: Wiley-Liss; 2002.
21. American Joint Committee on Cancer. AJCC Cancer Staging Handbook, 6th ed. New York: Springer Verlag; 2002.
22. American Joint Committee on Cancer, American Cancer Society, American College of Surgeons, Fleming ID. AJCC Cancer Staging Handbook From the AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven; 1998.
23. SAS OnlineDoc(r), version 9. Cary, NC: SAS Institute Inc; 2003.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
25. Cox DR. Regression models and life tables - series B (methodological). J R Stat Soc. 1972;34:187-220.
26. Sittel C, Eckel HE, Damm M, et al. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope. 2000;110:1012-1017.
27. Rucci L, Bocciolini C, Franchi A, et al. Epidermal growth factor receptor and p53 expression in T1-T2 glottic cancer involving the anterior or posterior commissure. Acta Otolaryngol. 2004;124:102-106.
28. Mendenhall WM, Riggs CE, Amdur RJ, et al. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck. Laryngoscope. 2003;113:546-551.
29. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.